Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 2116-2122

  Gravina, Giovanni Luca ^a   Mancini, Andrea ^a   Ranieri, Guido ^b   Pasquale, Boris Di ^b   Marampon, Francesco ^a   Clemente, Luigi Di ^b   Ricevuto, Enrico ^a   Festuccia, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Cancer associated fibroblasts; P75NTR; Prostatic stromal cells; Tumor progression

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; DESMIN; GELATINASE A; GELATINASE B; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VIMENTIN;

ARTICLE; CELL CULTURE; CELL POPULATION; CONCENTRATION (PARAMETERS); FIBROBLAST; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE CELL; MYOEPITHELIUM CELL; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; STROMA CELL; TUMOR XENOGRAFT;

ACTINS; BIOLOGICAL MARKERS; CELL PROLIFERATION; DESMIN; FIBROBLASTS; HUMANS; KERATIN-14; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PHENOTYPE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, NERVE GROWTH FACTOR; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 84876586373     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1892     Document Type: Article

References (39)

1. Barron DA and Rowley DR: The reactive stroma microenviron-ment and prostate cancer progression. Endocr Relat Cancer 19: R187-R204, 2012.
2. Ammirante M, Luo JL, Grivennikov S, Nedospasov S and Karin M: B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464: 302-305, 2010.
3. Iacopino F, Angelucci C and Sica G: Interactions between normal human fbroblasts and human prostate cancer cells in a co-culture system. Anticancer Res 32: 1579-1588, 2012.
4. Grubisha MJ, Cifuentes ME, Hammes SR and Defranco DB: A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β infuences reactive stromal cell regulation of prostate cancer cell motility. Mol Endocrinol 26: 940-954, 2012.
5. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D and Cunha GR: Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61: 8135-8142, 2001. (Pubitemid 33091604)
6. Cunha GR, Hayward SW, Wang YZ and Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10, 2003. (Pubitemid 37100079)
7. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fbroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999. (Pubitemid 29472907)
8. Barclay WW, Woodruff RD, Hall MC and Cramer SD: A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyper-plasia and prostate cancer. Endocrinology 146: 13-18, 2005. (Pubitemid 40051716)
9. Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR and Ricke WA: Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis 33: 1391-1398, 2012.
10. Tanner MJ, Welliver RC Jr, Chen M, Shtutman M, Godoy A, Smith G, Mian BM and Buttyan R: Effects of androgen receptor and androgen on gene expression in prostate stromal fbroblasts and paracrine signaling to prostate cancer cells. PLoS One 6: e16027, 2011.
11. Lai K P, Yamashita S, Huang CK, Yeh S and Chang C: Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-infammatory cytokines/chemokines. EMBO Mol Med 4: 791-807, 2012.
12. Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM and Bhowmick NA: Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res 10: 494-503, 2012.
13. Delsite R and Djakiew D: Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth. Prostate 41: 39-48, 1999. (Pubitemid 29390414)
14. Krygier S and Djakiew D: The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer. Anticancer Res 21: 3749-3755, 2001. (Pubitemid 34229237)
15. Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Ricevuto E, Vicentini C and Bologna M: In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neuro-trophin receptors in prostate carcinoma. Prostate 67: 1255-1264, 2007. (Pubitemid 47435773)
16. Rende M, Rambotti MG, Stabile AM, Pistilli A, Montagnoli C, Chiarelli MT and Mearini E: Novel localization of low affnity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: an immunohistochemical and ultracytochemical study. Prostate 70: 555-561, 2010.
17. Festuccia C, Vincentini C, di Pasquale AB, Aceto G, Zazzeroni F, Miano L and Bologna M: Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncol Res 7: 131-138, 1995.
18. Festuccia C, Angelucci A, Gravina GL, Muzi P, Miano R, Vicentini C and Bologna M: Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Int J Oncol 26: 1353-1362, 2005.
19. Sugimoto H, Mundel TM, Kieran MW and Kalluri R: Identifcation of fbroblast heterogeneity in the tumor microen-vironment. Cancer Biol Ther 5: 1640-1646, 2006.
20. De Wever O, Demetter P, Mareel M and Bracke M: Stromal myof-broblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238, 2008.
21. Festuccia C, Angelucci A, Gravina G, Eleuterio E, Vicentini C and Bologna M: Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement. Exp Cell Res 280: 1-11, 2002. (Pubitemid 35230362)
22. Festuccia C, Dolo V, Guerra F, et al: Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis 16: 513-528, 1998. (Pubitemid 29009587)
23. Schor SL, Schor AM and Rushton G: Fibroblasts from cancer patients display a mixture of both foetal and adult-like pheno-typic characteristics. J Cell Sci 90: 401-407, 1988.
24. Reinertsen T, Halgunset J, Viset T, Flatberg A, Haugsmoen LL and Skogseth H: Gene expressional changes in prostate fbro-blasts from cancerous tissue. APMIS 120: 558-571, 2012.
25. Cifone MG, Botti D, Festuccia C, Napolitano T, del Grosso E, Cavallo G, Chessa MA and Santoni A: Involvement of phos-pholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells. Cell Immunol 148: 247-258, 1993. (Pubitemid 23162620)
26. Ayala G, Tuxhorn JA, Wheeler TM, et al: Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 9: 4792-4801, 2003. (Pubitemid 37323282)
27. McAlhany SJ, Ayala GE, Frolov A, et al: Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 61: 182-191, 2004. (Pubitemid 39244705)
28. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fbroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
29. Rowley DR: What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17: 411-419, 1998. (Pubitemid 29331791)
30. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE and Rowley DR: Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62: 3298-3307, 2002. (Pubitemid 34602428)
31. Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF and Chung LW: Human prostate fbroblasts induce growth and confer castration resistance and metastatic potential in LNCaP cells. Eur Urol 58: 162-171, 2009.
32. Goetz JG, Minguet S, Navarro-Lérida I, Lazcano JJ, Samaniego R, Calvo E, et al: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146: 148-163, 2011.
33. Giatromanolaki A, Koukourakis MI, Koutsopoulos A, Mendrinos S and Sivridis E: The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer. Cancer Biol Ther 13: Nov 1, 2012 (Epub ahead of print).
34. Freeman MR, Yang W and Di Vizio D: Caveolin-1 and prostate cancer progression. Adv Exp Med Biol 729: 95-110, 2012.
35. Giannoni E, Taddei ML, Parri M, Bianchini F, Santosuosso M, Grifantini R, Fibbi G, Mazzanti B, Calorini L and Chiarugi P: EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fbroblasts. J Mol Med (Berl): Aug 19, 2012 (Epub ahead of print).
36. Franco OE, Shaw AK, Strand DW and Hayward SW: Cancer associated fbroblasts in cancer pathogenesis. Semin Cell Dev Biol 21: 33-39, 2010.
37. Daja MM, Niu X, Zhao Z, Brown JM and Russell PJ: Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis 6: 15-26, 2003. (Pubitemid 36432616)
38. Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D and Peehl DM: Expression of matrix metalloproteinase-2 and-9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and-2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 191: 208-216, 2002. (Pubitemid 34273469)
39. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA and Lichtinghagen R: Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate 50: 38-45, 2002. (Pubitemid 34044863)